Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed May 9, 2017 · 10-Q · 39 days after period end · 0001280776-17-000029
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$12.60M | -$9.59M | -$14.76M | -$10.75M |
| EPS Diluted | -$0.39 | -$0.31 | -$0.62 | -$24.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 9, 2017 · 39 d after period end
